Table 11.
Reported cases of HIV/AIDS for male adults and adolescents, by race/ethnicity
and exposure category,1999–2002—30 areas with confidential
name-based HIV infection reporting
|
White, not Hispanic
|
|
|
Year of report
|
|
Exposure category
|
1999
|
2000
|
2001
|
2002
|
|
Male-to-male sexual contact
|
5,480
|
4,859
|
5,063
|
5,095
|
|
Injection drug use
|
695
|
549
|
572
|
475
|
|
Male-to-male sexual contact and injection drug
use
|
553
|
469
|
369
|
358
|
|
Hemophilia/coagulation disorder
|
36
|
29
|
24
|
17
|
|
Heterosexual contact:
|
368
|
296
|
308
|
242
|
|
~~Sex with injection drug user
|
84
|
82
|
56
|
59
|
|
~~Sex with person with hemophilia
|
0
|
2
|
0
|
0
|
|
~~Sex with HIV-infected transfusion recipient
|
2
|
1
|
3
|
4
|
|
~~Sex with HIV-infected person, risk not specified
|
282
|
211
|
249
|
179
|
|
Receipt of blood transfusion, blood components,
or tissue
|
40
|
32
|
34
|
31
|
|
Other/risk not reported
or identifieda
|
1,297
|
1,263
|
1,264
|
1,776
|
|
Total
|
8,469
|
7,497
|
7,634
|
7,994
|
|
Black, not Hispanic
|
|
|
Year of report
|
|
Exposure category
|
1999
|
2000
|
2001
|
2002
|
|
Male-to-male sexual contact
|
3,052
|
2,810
|
2,877
|
2,716
|
|
Injection drug use
|
1,364
|
1,185
|
933
|
787
|
|
Male-to-male sexual contact and injection drug
use
|
334
|
238
|
249
|
188
|
|
Hemophilia/coagulation disorder
|
14
|
5
|
7
|
4
|
|
Heterosexual contact:
|
1,762
|
1,649
|
1,517
|
1,254
|
|
~~Sex with injection drug user
|
279
|
225
|
215
|
147
|
|
~~Sex with person with hemophilia
|
6
|
1
|
3
|
1
|
|
~~Sex with HIV-infected transfusion recipient
|
9
|
5
|
8
|
12
|
|
~~Sex with HIV-infected person, risk not specified
|
1,468
|
1,418
|
1,291
|
1,094
|
|
Receipt of blood transfusion, blood components,
or tissue
|
43
|
38
|
24
|
29
|
|
Other/risk not reported
or identifieda
|
3,307
|
3,048
|
3,282
|
3,915
|
|
Total
|
9,876
|
8,973
|
8,889
|
8,893
|
|
Hispanic
|
|
|
Year of report
|
|
Exposure category
|
1999
|
2000
|
2001
|
2002
|
|
Male-to-male sexual contact
|
1,134
|
1,062
|
1,115
|
1,224
|
|
Injection drug use
|
335
|
314
|
324
|
257
|
|
Male-to-male sexual contact and injection drug
use
|
96
|
78
|
68
|
57
|
|
Hemophilia/coagulation disorder
|
1
|
2
|
0
|
2
|
|
Heterosexual contact:
|
241
|
209
|
242
|
207
|
|
~~Sex with injection drug user
|
42
|
42
|
32
|
34
|
|
~~Sex with person with hemophilia
|
0
|
0
|
0
|
1
|
|
~~Sex with HIV-infected transfusion recipient
|
0
|
3
|
2
|
2
|
|
~~Sex with HIV-infected person, risk not specified
|
199
|
164
|
208
|
170
|
|
Receipt of blood transfusion, blood components,
or tissue
|
8
|
4
|
5
|
8
|
|
Other/risk not reported
or identifieda
|
604
|
654
|
677
|
787
|
|
Total
|
2,419
|
2,323
|
2,431
|
2,542
|
|
Asian/Pacific Islander
|
|
|
Year of report
|
|
Exposure category
|
1999
|
2000
|
2001
|
2002
|
|
Male-to-male sexual contact
|
60
|
42
|
58
|
64
|
|
Injection drug use
|
4
|
4
|
7
|
2
|
|
Male-to-male sexual contact and injection drug
use
|
1
|
1
|
3
|
2
|
|
Hemophilia/coagulation disorder
|
0
|
0
|
0
|
1
|
|
Heterosexual contact:
|
13
|
10
|
9
|
8
|
|
~~Sex with injection drug user
|
3
|
0
|
0
|
0
|
|
~~Sex with HIV-infected transfusion recipient
|
0
|
0
|
1
|
0
|
|
~~Sex with HIV-infected person, risk not specified
|
10
|
10
|
8
|
8
|
|
Receipt of blood transfusion, blood components,
or tissue
|
1
|
0
|
1
|
0
|
|
Other/risk not reported
or identifieda
|
21
|
44
|
37
|
45
|
|
Total
|
100
|
101
|
115
|
122
|
|
American Indian/Alaska Native
|
|
|
Year of report
|
|
Exposure category
|
1999
|
2000
|
2001
|
2002
|
|
Male-to-male sexual contact
|
77
|
65
|
55
|
68
|
|
Injection drug use
|
17
|
15
|
17
|
15
|
|
Male-to-male sexual contact and injection drug
use
|
19
|
10
|
21
|
8
|
|
Hemophilia/coagulation disorder
|
0
|
0
|
0
|
0
|
|
Heterosexual contact:
|
13
|
10
|
11
|
8
|
|
~~Sex with injection drug user
|
3
|
3
|
5
|
3
|
|
~~Sex with HIV-infected transfusion recipient
|
1
|
0
|
0
|
0
|
|
~~Sex with HIV-infected person, risk not specified
|
9
|
7
|
6
|
5
|
|
Receipt of blood transfusion, blood components,
or tissue
|
1
|
0
|
1
|
0
|
|
Other/risk not reported
or identifieda
|
22
|
13
|
17
|
18
|
|
Total
|
149
|
113
|
122
|
117
|
|
Total casesb
|
21,112
|
19,143
|
19,406
|
19,678
|
Data include male adults and adolescents with a diagnosis of HIV infection. This includes male adults and adolescents with a diagnosis of HIV infection (not AIDS), a diagnosis of HIV infection and a later AIDS diagnosis, and concurrent diagnoses of HIV infection and AIDS.
Since 1998, the following 30 areas have had laws or regulations requiring confidential name-based HIV infection reporting: Alabama, Arkansas, Arizona, Florida, Colorado, Iowa, Idaho, Indiana, Louisiana, Michigan, Minnesota, Mississippi, Missouri, Nebraska, New Jersey, New Mexico, Nevada, North Carolina, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Utah, Virginia, Wisconsin, West Virginia, Wyoming, and the U.S. Virgin Islands. Since July 1997, Florida has had confidential name-based HIV infection reporting only for new diagnoses.
a Includes hemophilia, blood transfusion, perinatal, and risk not reported or not identified.
b Includes male adults and adolescents of unknown race or multiple races.
Added on: June 14, 2004
Centers for Disease Control & Prevention
National Center for HIV, STD, and TB Prevention
Divisions of HIV/AIDS Prevention
Contact Us
|
National Center for HIV, STD and TB Prevention
